VMP 42275611000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Olanzapine 15mg tablets
BNF code 040201060AAALAL
Virtual Therapeutic Moiety Olanzapine
Date identifier became valid 22 Sep 2023
Previous product identifier 376807001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Olanzapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 15.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Olanzapine 15mg tablets (A A H Pharmaceuticals Ltd)
Olanzapine 15mg tablets (Accord-UK Ltd)
Olanzapine 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Olanzapine 15mg tablets (Bristol Laboratories Ltd)
Olanzapine 15mg tablets (Crescent Pharma Ltd)
Olanzapine 15mg tablets (CST Pharma Ltd)
Olanzapine 15mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Olanzapine 15mg tablets (Krka UK Ltd)
Olanzapine 15mg tablets (Medihealth (Northern) Ltd)
Olanzapine 15mg tablets (Milpharm Ltd)
Olanzapine 15mg tablets (Sigma Pharmaceuticals Plc)
Olanzapine 15mg tablets (Sun Pharma UK Ltd)
Olanzapine 15mg tablets (Teva UK Ltd)
Zalasta 15mg tablets (CST Pharma Ltd)
Zyprexa 15mg tablets (Neon Healthcare Ltd)
Zyprexa 15mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Olanzapine 15mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback